{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:22:33Z","timestamp":1769271753811,"version":"3.49.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Venovenous extracorporeal membrane oxygenation (VV ECMO) is an established support option for patients with very severe respiratory failure and played an important role during the coronavirus disease 2019 (COVID-19) pandemic. Bacteria and fungi can lead to severe infectious complications in critically ill patients. The aim of this study was to describe the microbiological spectrum of bacteria and fungi detected in patients with COVID-19-associated respiratory failure supported with VV ECMO in our center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective single-center analysis included all patients with COVID-19-associated respiratory failure supported with VV ECMO in our center between March 2020 and May 2022. All findings from microbiological samples, taken as part of clinical routine assessment from initiation of VV ECMO until day\u00a030 were included. Samples were described by site and time of detection and microbiological characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From March 2020 through May\u00a02022, 88\u00a0patients with COVID-19-associated respiratory failure received VV ECMO support at our center. In 83\/88 patients (94.3%), one or more pathogens were found in microbiological samples. Most pathogens were isolated from samples from the respiratory tract (88.6%). Earliest detection occurred in samples from the respiratory tract with a\u00a0median time of 5\u00a0days to first detection. The most frequently detected pathogens were\n                      <jats:italic>Staphylococcus spp<\/jats:italic>\n                      .,\n                      <jats:italic>Candida spp., Klebsiella spp., Escherichia coli<\/jats:italic>\n                      and\n                      <jats:italic>Enterococcus spp.<\/jats:italic>\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this cohort of severely ill COVID-19 patients receiving VV ECMO support, pathogens were frequently detected.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00063-024-01245-6","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T10:32:50Z","timestamp":1738319570000},"page":"36-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Microbiological findings in a\u00a0cohort of patients with coronavirus disease 2019 and venovenous extracorporeal membrane oxygenation","Nachweis von Mikroorganismen in einer Kohorte von Patienten mit Coronaviruserkrankung 2019 und venoven\u00f6ser extrakorporaler Membranoxygenierung"],"prefix":"10.1007","volume":"120","author":[{"given":"Christian","family":"Gl\u00fcck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugen","family":"Widmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawid L.","family":"Staudacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Wengenmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4056-3652","authenticated-orcid":false,"given":"Alexander","family":"Supady","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"1245_CR1","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00134-019-05847-z","volume":"46","author":"D Abrams","year":"2020","unstructured":"Abrams\u00a0D, Grasselli\u00a0G, Schmidt\u00a0M et\u00a0al (2020) ECLS-associated infections in adults: what we know and what we don\u2019t yet know. Intensive Care Med 46:182\u2013191","journal-title":"Intensive Care Med"},{"key":"1245_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1097\/MAT.0000000000001422","volume":"67","author":"J Badulak","year":"2021","unstructured":"Badulak\u00a0J, Antonini\u00a0MV, Stead\u00a0CM et\u00a0al (2021) Extracorporeal Membrane Oxygenation for COVID-19: Updated 2021 Guidelines from the Extracorporeal Life Support Organization. ASAIO\u00a0J 67:485\u2013495","journal-title":"ASAIO J"},{"key":"1245_CR3","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/S0140-6736(21)01960-7","volume":"398","author":"RP Barbaro","year":"2021","unstructured":"Barbaro\u00a0RP, Maclaren\u00a0G, Boonstra\u00a0PS et\u00a0al (2021) Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry. Lancet 398:1230\u20131238","journal-title":"Lancet"},{"key":"1245_CR4","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1001\/jama.2019.9302","volume":"322","author":"D Brodie","year":"2019","unstructured":"Brodie\u00a0D, Slutsky\u00a0AS, Combes\u00a0A (2019) Extracorporeal Life Support for Adults With Respiratory Failure and Related Indications: A\u00a0Review. JAMA 322:557\u2013568","journal-title":"JAMA"},{"key":"1245_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s15010-021-01602-z","volume":"49","author":"WH Chong","year":"2021","unstructured":"Chong\u00a0WH, Saha\u00a0BK, Ananthakrishnan\u00a0R et\u00a0al (2021) State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection 49:591\u2013605","journal-title":"Infection"},{"key":"1245_CR6","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","volume":"378","author":"A Combes","year":"2018","unstructured":"Combes\u00a0A, Hajage\u00a0D, Capellier\u00a0G et\u00a0al (2018) Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. N\u00a0Engl J Med 378:1965\u20131975","journal-title":"N Engl J Med"},{"key":"1245_CR7","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1007\/s00134-020-06248-3","volume":"46","author":"A Combes","year":"2020","unstructured":"Combes\u00a0A, Peek\u00a0GJ, Hajage\u00a0D et\u00a0al (2020) ECMO for severe ARDS: systematic review and individual patient data meta-analysis. Intensive Care Med 46:2048\u20132057","journal-title":"Intensive Care Med"},{"key":"1245_CR8","doi-asserted-by":"crossref","unstructured":"De Hesselle ML, Borgmann S, Rieg S et\u00a0al (2022) Invasiveness of Ventilation Therapy Is Associated to Prevalence of Secondary Bacterial and Fungal Infections in Critically Ill COVID-19\u00a0Patients. J\u00a0Clin Med 11:","DOI":"10.3390\/jcm11175239"},{"key":"1245_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1164\/rccm.202009-3400OC","volume":"203","author":"A Fekkar","year":"2021","unstructured":"Fekkar\u00a0A, Lampros\u00a0A, Mayaux\u00a0J et\u00a0al (2021) Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU. Am J Respir Crit Care Med 203:307\u2013317","journal-title":"Am J Respir Crit Care Med"},{"key":"1245_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cmi.2020.07.041","volume":"27","author":"C Garcia-Vidal","year":"2021","unstructured":"Garcia-Vidal\u00a0C, Sanjuan\u00a0G, Moreno-Garcia\u00a0E et\u00a0al (2021) Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a\u00a0retrospective cohort study. Clin Microbiol Infect 27:83\u201388","journal-title":"Clin Microbiol Infect"},{"key":"1245_CR11","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1001\/jama.2018.14276","volume":"320","author":"EC Goligher","year":"2018","unstructured":"Goligher\u00a0EC, Tomlinson\u00a0G, Hajage\u00a0D et\u00a0al (2018) Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a\u00a0Post Hoc Bayesian Analysis of a\u00a0Randomized Clinical Trial. JAMA 320:2251\u20132259","journal-title":"JAMA"},{"key":"1245_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.chest.2021.04.002","volume":"160","author":"G Grasselli","year":"2021","unstructured":"Grasselli\u00a0G, Scaravilli\u00a0V, Mangioni\u00a0D et\u00a0al (2021) Hospital-Acquired Infections in Critically Ill Patients With COVID-19. Chest 160:454\u2013465","journal-title":"Chest"},{"key":"1245_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S2213-2600(18)30452-1","volume":"7","author":"L Munshi","year":"2019","unstructured":"Munshi\u00a0L, Walkey\u00a0A, Goligher\u00a0E et\u00a0al (2019) Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a\u00a0systematic review and meta-analysis. Lancet Respir Med 7:163\u2013172","journal-title":"Lancet Respir Med"},{"key":"1245_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00134-020-06294-x","volume":"47","author":"Network C-IGOBOTR","year":"2021","unstructured":"Network C\u2011IGOBOTR, C\u2011ICUI (2021) Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a\u00a0prospective cohort study. Intensive Care Med 47:60\u201373","journal-title":"Intensive Care Med"},{"key":"1245_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas\u00a0PG, Kauffman\u00a0CA, Andes\u00a0DR et\u00a0al (2016) Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 62:409\u2013417","journal-title":"Clin Infect Dis"},{"key":"1245_CR16","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1164\/rccm.202106-1354OC","volume":"204","author":"CO Pickens","year":"2021","unstructured":"Pickens\u00a0CO, Gao\u00a0CA, Cuttica\u00a0MJ et\u00a0al (2021) Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia. Am J Respir Crit Care Med 204:921\u2013932","journal-title":"Am J Respir Crit Care Med"},{"key":"1245_CR17","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1164\/rccm.202101-0030OC","volume":"204","author":"A Rouze","year":"2021","unstructured":"Rouze\u00a0A, Martin-Loeches\u00a0I, Povoa\u00a0P et\u00a0al (2021) Early Bacterial Identification among Intubated Patients with COVID-19 or Influenza Pneumonia: A\u00a0European Multicenter Comparative Clinical Trial. Am J Respir Crit Care Med 204:546\u2013556","journal-title":"Am J Respir Crit Care Med"},{"key":"1245_CR18","doi-asserted-by":"publisher","first-page":"8557","DOI":"10.21037\/apm-21-833","volume":"10","author":"L Sang","year":"2021","unstructured":"Sang\u00a0L, Xi\u00a0Y, Lin\u00a0Z et\u00a0al (2021) Secondary infection in severe and critical COVID-19\u00a0patients in China: a\u00a0multicenter retrospective study. Ann Palliat Med 10:8557\u20138570","journal-title":"Ann Palliat Med"},{"key":"1245_CR19","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/s00134-022-06815-w","volume":"48","author":"A Supady","year":"2022","unstructured":"Supady\u00a0A, Combes\u00a0A, Barbaro\u00a0RP et\u00a0al (2022) Respiratory indications for ECMO: focus on COVID-19. Intensive Care Med 48:1326\u20131337","journal-title":"Intensive Care Med"},{"key":"1245_CR20","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1111\/aor.14365","volume":"46","author":"E Widmeier","year":"2022","unstructured":"Widmeier\u00a0E, Wengenmayer\u00a0T, Maier\u00a0S et\u00a0al (2022) Extracorporeal membrane oxygenation during the coronavirus disease 2019 pandemic: Continued observations from a\u00a0retrospective single-center registry. Artif Organs 46:2329\u20132333","journal-title":"Artif Organs"},{"key":"1245_CR21","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1111\/aor.14270","volume":"46","author":"E Widmeier","year":"2022","unstructured":"Widmeier\u00a0E, Wengenmayer\u00a0T, Maier\u00a0S et\u00a0al (2022) Extracorporeal membrane oxygenation during the first three waves of the coronavirus disease 2019 pandemic: A\u00a0retrospective single-center registry study. Artif Organs 46:1876\u20131885","journal-title":"Artif Organs"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01245-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-024-01245-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-024-01245-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T15:54:11Z","timestamp":1765900451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-024-01245-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":21,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1245"],"URL":"https:\/\/doi.org\/10.1007\/s00063-024-01245-6","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"assertion":[{"value":"1 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The following statement was added: \u201cThe supplement containing this article is not sponsored by industry.\u201d","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have completed the ICMJE form (available upon request from the corresponding author). D.L.\u00a0Staudacher received honoraria for lecturing Abiomed, AstraZeneca, Getinge, Medtronic, Dahlhausen and Orion Pharma, all of which are unrelated to this manuscript. T.\u00a0Wengenmayer reports lecture fees from Getinge and Resuscitec. A.\u00a0Supady reports research grants and lecture fees from CytoSorbents, lecture fees from Getinge, Resuscitec, AstraZeneca and Abiomed and travel support and consulting fees from ARTCLINE, all outside the submitted work. A.\u00a0Supady is member of the scientific committee of EuroELSO. C.\u00a0Gl\u00fcck, E.\u00a0Widmeier and S.\u00a0Maier declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Data collection was approved by the institutional ethics committee of the University of Freiburg (EK 151\/14); due to the retrospective and observational nature of the study, the need for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}